Synapse - Works

Results (5377)

Characterizing patterns of mTORC1 activation across sarcoma subtypes using single-sample gene set enrichment analysis (ssGSEA) and a national biomarker database

Meeting Abstract

Lefler, D. S.; Elliott, A.; Blomain, E.; Maki, R. G.; Modiano, J.; Seeber, A.; Riedel, R. F.; Sarver, A.; Espejo-Freire, A. P.; Khushman, M. M.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group

Meeting Abstract

Burtness, B.; Flamand, Y.; Quon, H.; Weinstein, G. S.; Mehra, R.; Garcia, J. J.; Kim, S.; O'Malley, B. W. Jr; Ozer, E.; Koch, W.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Efficacy and safety of erdafitinib in patients with advanced or metastatic cholangiocarcinoma and FGFR alterations: Pooled analysis of RAGNAR and LUC2001 studies

Meeting Abstract

Pant, S.; Park, J. O.; Su, W. C.; Schuler, M. H.; Loriot, Y.; Iyer, G.; Doi, T.; Qin, S.; Tabernero, J.; Prenen, H.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Efficacy and genomic analysis of HER2-mutant, metastatic triple-negative breast cancer treated with neratinib alone or in combination with trastuzumab in the phase 2 SUMMIT basket trial

Meeting Abstract

Jhaveri, K. L.; Hurvitz, S. A.; Brufsky, A.; Bose, R.; de Miguel, M. J.; Evron, E.; Unni, N.; Reid, S. A.; Quinn, D. I.; Mahalingam, D.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Long-term survival outcomes of patients (pts) with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3

Meeting Abstract

Oluwole, O. O.; Ghobadi, A.; Cassaday, R. D.; Park, J. H.; Houot, R.; Logan, A.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

First-in-human study of RLY-2608, a pan-mutant and isoform selective PI3Kα inhibitor, as a single agent in patients (pts) with advanced solid tumors and in combination with fulvestrant in pts with advanced breast cancer

Meeting Abstract

Saura, C.; Sanz, L.; Kim, J.; Jhaveri, K. L.; Guerrero, A.; Ortega, P. T.; Schott, A. F.; Curigliano, G.; Perez, C. A.; Nanda, R.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Zanidatamab in previously-treated HER2-positive (HER2+) biliary tract cancer (BTC): Overall survival (OS) and longer follow-up from the phase 2b HERIZON-BTC-01 study

Meeting Abstract

Pant, S.; Fan, J.; Oh, D. Y.; Choi, H. J.; Kim, J. W.; Chang, H. M.; Bao, L.; Sun, H. C.; Macarulla, T.; Xie, F.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation

Meeting Abstract

Goetz, M. P.; Wander, S. A.; Bachelot, T.; Batist, G.; Cortes, J.; Cristofanilli, M.; Curigliano, G.; De Nonneville, A.; Gal-Yam, E. N.; Jhaveri, K. L.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (OPBC-03/SAKK 23/16/IBCSG 57-18/ABCSG-53/GBG-101-TAXIS)

Meeting Abstract

Weber, W. P.; Matrai, Z.; Hayoz, S.; Tausch, C.; Henke, G.; Zimmermann, F.; Montagna, G.; Fitzal, F.; Gnant, M.; Ruhstaller, T.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Lenvatinib plus pembrolizumab (L plus P) vs sunitinib (S) in advanced renal cell carcinoma (aRCC): Patterns of progression and subsequent therapy in the CLEAR trial

Meeting Abstract

Grünwald, V.; Motzer, R. J.; Keizman, D.; Bedke, J.; Schmidinger, M.; Staehler, M. D.; Matveev, V. B.; George, S.; Hutson, T. E.; Vaishampayan, U. N.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save